Progyny, Inc. (PGNY) · Aug 6, 2026 · Company update

Profit clears the high end, but revenue guidance gets trimmed

Profit clears the high end, but revenue guidance gets trimmed

The quarter landed above its own profit expectations. Prior guidance called for revenue of $342.0–$355.0 million, Adjusted EBITDA of $58.0–$62.0 million, and Adjusted EPS of $0.50–$0.53; actual results reached $350.5 million, $62.1 million, and $0.55, respectively. That puts revenue toward the upper half of the range and both profit measures slightly above the high end.

Metric2Q 20262Q 2025 / prior expectationRead
Revenue$350.5M$332.9M; prior guide $342.0–$355.0M+5.3% year over year; within guide
Gross profit$89.3M$79.0M+13%; margin expanded to 25.5%
Net income$28.1M$17.1M; prior guide $25.8–$28.7MAbove prior-year period; near high end
Adjusted EPS$0.55$0.48; prior guide $0.50–$0.53Above the high end
Adjusted EBITDA$62.1M$57.9M; prior guide $58.0–$62.0MSlightly above the high end
Adjusted EBITDA margin17.7%17.4%Modest expansion
Operating cash flow$50.4M$55.5MLower year over year in the quarter

Underlying growth was stronger than the headline revenue increase suggests. The discontinued large client contributed $17.2 million in the prior-year quarter but nothing in 2Q 2026; excluding that distortion, revenue grew 11.0%. Average members increased to 7.185 million from 6.743 million, while utilization also improved, supporting the view that demand and engagement were better than the reported 5.3% growth rate implies (Financial Highlights; Key Metrics).

Margin execution was the clearest operational positive. Gross margin rose to 25.5% from 23.7%, and operating income increased to $40.0 million from $24.4 million as gross profit expanded faster than operating expenses (Income Statement). Adjusted EBITDA margin improved only modestly to 17.7%, however, because Progyny continued investing in its platform (Adjusted EBITDA reconciliation). The EPS improvement also benefited from a much smaller share count—82.1 million diluted shares versus 89.6 million—following substantial repurchases (Income Statement; Balance Sheet).

The forward picture is not a clean raise. Full-year revenue guidance moved from $1.365–$1.405 billion to $1.360–$1.385 billion, lowering both the midpoint and the ceiling. Full-year Adjusted EBITDA guidance was narrowed from $232–$244 million to $233–$240 million, while Adjusted EPS rose from $1.98–$2.09 to $2.04–$2.10 (Financial Outlook). The combination says current profitability is holding up better than feared, but management is being more cautious on top-line conversion and the upside range for the year.

Net read: a good quarter offset by a more cautious outlook. The earnings beat is real—especially on Adjusted EPS and EBITDA—but it is modest relative to the prior range, and the revenue-guidance trim prevents this from reading as a broad upside revision. The $200 million buyback authorization, no debt, and $236.9 million of cash and marketable securities add financial support, but the main expectation reset is mixed rather than decisively positive (Balance Sheet; Cash Flow statement; Share Repurchase Activity).

Original filing on SEC EDGAR

More Progyny, Inc. news

Profit clears the high end, but revenue guidance gets trimmed | PGNY Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.